CHEMLOK 8212

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Skin sensitization Category 1 Respiratory sensitization Category 1 Carcinogenicity Category 1B Specific target organ systemic toxicity (single exposure) Category 2 blood system Specific target organ systemic toxicity (single exposure) Category 1 Cardiovascular system, Central nervous system, intestinal tract, Stomach, Respiratory system Specific target organ systemic toxicity (repeated exposure) Category 1 Liver, Nervous System Specific target organ systemic toxicity (repeated exposure) Category 2 blood system Hazardous to the aquatic environment - acute hazard Category 2 Hazardous to the aquatic environment - chronic hazard Category 2

Signal word

DANGER

Hazard statements

May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause cancer. May cause damage to organs.(blood system) Causes damage to organs.(Cardiovascular system, Central nervous system, intestinal tract, Stomach, Respiratory system) Causes damage to organs through prolonged or repeated exposure.(Liver, Nervous System) May cause damage to organs through prolonged or repeated exposure.(blood system) Toxic to aquatic life. Toxic to aquatic life with long lasting effects. 300001003602

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves. Use personal protective equipment as required. In case of inadequate ventilation wear respiratory protection. Do not breathe dust, fume, mist, vapors, spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment.

Response

Get medical advice, attention if you feel unwell. IF exposed: Call a POISON CENTER or doctor, physician. Specific treatment (see supplemental first aid instructions on this label). IF INHALED: If breathing is difficult, remove to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor, physician. IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice, attention. Wash contaminated clothing before reuse. Collect spillage.

Storage

Store locked up.

Disposal

Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.

2.3 Other hazards

This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s). Acute: Vapor harmful; may affect the brain or nervous system causing dizziness, headache or nausea. May cause central nervous system depression characterized by the following progressive steps: headache, dizziness, staggering gait, confusion, unconsciousness or coma. Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. May cause skin irritation. May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses.May cause eye irritation. Chronic: May cause kidney damage. Prolonged or repeated contact may result in dermatitis. The nitrogen substituted aromatic in this product gave positive results for mutagenicity in an Ames Assay study while two other mutagenicity studies proved negative. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequate evidence" from human health studies to assess whether carbon black causes cancer in humans. Further, epidemiological evidence from well-conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans. Methylene chloride has been classified for carcinogenicity by IARC and by NTP as sufficient evidence for carcinogenicity in experimental animals; insufficient evidence in humans. Use of this product should comply with the